The Hidden API Concentration Risk Facing Pharma Procurement
Nearly half the world's API manufacturing sits in one country. See what pharma procurement teams should track to manage that concentration risk.
Read articlePractical analysis on supply chain risk, financial exposure, and procurement strategy, written for enterprise teams who need to act, not just read.
Nearly half the world's API manufacturing sits in one country. See what pharma procurement teams should track to manage that concentration risk.
Read article
Medical device supply chain risk is rising as China's rare earth export controls hit MRI and X-ray equipment makers with no substitute…
Read article
Industrial machinery contract risk is rising as China tightens rare earth export licensing. See which contract clauses procurement teams should revisit now.
Read article
HVAC refrigerant compliance risk is rising as EPA rules on HFCs and A2L systems shift. Here's how procurement teams should monitor supplier…
Read article
Pharma contract manufacturing risk often hides in stale CDMO quality agreements. See what 2026 FDA warning letter data shows before your next…
Read article
HVAC supplier financial distress often hides behind stabilizing headline numbers. Here are the early warning signs procurement teams miss.
Read article
Medical device supplier risk monitoring needs real-time data, not quarterly reports. See what 2026 recall trends and FDA's QMSR shift reveal.
Read article
Rare earth magnet supply chain risk sits inside industrial machinery motors and drives. See why China's 2026 export controls matter to procurement.
Read article
Legacy shortage alerts arrive after the disruption already hit. See how AI supply chain risk monitoring flags pharma supplier and API risk…
Read article
Reactive procurement costs HVAC teams millions when compressor and refrigerant suppliers fail without warning. See what proactive risk monitoring changes.
Read article
Medical device contract renewals often skip supplier financial and QMSR compliance checks. Here's what procurement teams should verify first.
Read article
Most pharma risk programs stop at the API supplier. The real exposure often sits one tier deeper, in a single shared key…
Read article